Oncology
For years, Sara worked in a hospital, making care possible for others. Now, after being diagnosed with breast cancer, she was the one in need of care.
Explore end-to-end solutions throughout development — from portfolio optimization and regulatory strategy, to Phase I-IV clinical trials, market access planning, and more.
See solutionsWHAT WE DO
HOW WE DO IT
Utilize our expertise across therapeutic areas, combining innovative trial designs, leading clinical and regulatory expertise, global reach, and a passion for changing patient lives.
See expertiseTherapeutic Expertise
Cross-Therapeutic Expertise
Our experts help you stay at the forefront of the industry - and ahead of change.
See insightsNew Medicines, Novel Insights
Discussions on Diversity
Thinking about joining a clinical trial? Learn the drug development process, what it’s like to participate, how to find a trial, and answers to frequently asked questions.
Learn moreFor years, Sara worked in a hospital, making care possible for others. Now, after being diagnosed with breast cancer, she was the one in need of care.
It took 10 years of treatments for Anisha's IBD to enter remission. But it came back in 2019 — and just as she was about to start treatment, the pandemic hit.
Want to collaborate with us to offer clinical trials at your site? We would welcome the opportunity to discuss.
Learn moreWe are one of the largest CROs in the world, speeding life-changing medicine to market by engaging patients With Heart™. Learn about who we are, what we do, and what we believe.
About ParexelWhat can we help you find today?
Drug development is moving beyond the clinic into real-world therapeutic evaluation—and ever closer to the patient’s daily life and medical needs. Applications of biosensors for remote data collection offer enormous opportunities to better engage patients in research and to deliver therapies that provide greater value for the patients who use them. In this report, Parexel shares insights on how to integrate multiple biosensors in a research approach that improves patient experience, delivers end-to-end remote data collection, and presages greater efficiencies that will ultimately reduce time to market.
Related Insights
Blog
Actigraphy advances a patient-first approach: Reduce patient burden — and make the most of valuable data
Oct 15, 2021
Webinar
Use of AI to develop health economic evidence for optimized patient access
Sep 6, 2023
Blog
Highlights from ISMPP Asia Pacific Meeting 2021
Sep 20, 2021
Report
New Medicines, Novel Insights: Achieving patient-guided drug development
Oct 30, 2023
Video
Part Four: Gaps to fill with diversity and inclusion in clinical trials
Aug 17, 2021
Podcast
RBQM Podcast Series | Episode 2: Cultivating Risk-based Behaviors
Mar 18, 2022
Article
How biotechs can strengthen their value story with advanced analytics
Feb 15, 2022
Blog
CNS Summit Recap: The Future is Collaborative
Nov 22, 2021
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Blog
Clinical pharmacology, modeling and simulation to support FIH study design
Oct 21, 2021
Article
3 ways to incorporate DE&I in your communications strategy
Sep 29, 2021
Blog
Capitalizing on sensors in clinical trials
Sep 20, 2021